Vitreal Cytokine Profile Differences Between Eyes With Epiretinal Membranes or Macular Holes. by Zandi, Souska et al.
Retinal Cell Biology
Vitreal Cytokine Profile Differences Between Eyes With
Epiretinal Membranes or Macular Holes
Souska Zandi,1 Christoph Tappeiner,2,3 Isabel B. Pfister,1,3 Alain Despont,3,4 Robert Rieben,3,4
and Justus G. Garweg1,3
1Swiss Eye Institute and Clinic for Vitreoretinal Diseases, Berner Augenklinik am Lindenhofspital, Bern, Switzerland
2Department of Ophthalmology, Inselspital, Bern, Switzerland
3University of Bern, Bern, Switzerland
4Department of Clinical Research, University of Bern, Bern, Switzerland
Correspondence: Justus G. Garweg,
Swiss Eye Institute, Berner Augen-
klinik am Lindenhofspital, Bremgar-
tenstrasse 119, CH - 3012 Bern;
garweg@swiss-eye-institute.com.
Submitted: August 31, 2016
Accepted: October 11, 2016
Citation: Zandi S, Tappeiner C, Pfister
IB, Despont A, Rieben R, Garweg JG.
Vitreal cytokine profile differences
between eyes with epiretinal mem-
branes or macular holes. Invest Oph-
thalmol Vis Sci. 2016;57:6320–6326.
DOI:10.1167/iovs.16-20657
PURPOSE. Cytokines play an important role in cell signaling in inflammatory and repair
processes, also within the posterior segment of the eye. These molecules are thus implicated
in the pathophysiology of several vitreoretinal diseases. In the present study, we compared
vitreal cytokine profiles in patients with idiopathic epiretinal membranes (ERMs) and
idiopathic full-thickness macular holes (MHs) without epiretinal membranes.
METHODS. Native vitreal humor was collected during elective pars plana vitrectomy for the
treatment of macular pathologies (group 1: ERM; group 2: MH) from patients without any
other ocular or systemic disease. The concentrations of 43 chemokines and cytokines were
measured in parallel by multiplex beads analysis. Intergroup comparisons were conducted
using the Mann-Whitney U test and Bonferroni’s correction, at a level of significance of P <
0.0012.
RESULTS. Vitreal samples from 31 patients with ERMs (group 1) and from 30 with MHs (group
2) were analyzed. For 12 of the tested cytokines (GM-CSF, MCP-1, MIF, CCL15, CCL20, CCL17,
CX3CL1, CXCL10, CXCL16, and TGF-b-1, -2, and -3), no intergroup differences were revealed;
for the other 31, the concentrations were higher in the ERM than in the MH group (P <
0.0012 in each case).
CONCLUSIONS. The vitreal levels of 72% of the tested cytokines were higher in ERM than in MH.
This indicates that even in the absence of clinical markers, activation of inflammatory and
profibrotic mechanisms is implicated in the progression of ERMs. Although frequently used as
such in the past, eyes with ERMs should be considered with caution as a healthy control
group.
Keywords: biomarkers, chemokines, cytokines, cytokine profiles, epiretinal membrane,
fibrosis, gliosis, interleukins (IL), macular hole, tumour necrosis factor (TNF)
Cytokines are cell-signaling proteins that mediate diversephysiological processes. They also play a crucial role in
various inflammatory processes, as well as in wound healing
and fibrotic scarification.1 Fibrosis is a process that is
characterized by an exuberant formation of connective tissue,
which entails the production of collagens and glycosaminogly-
cans by activated fibroblasts. In the retina, tissue-resident cells,
such as glia and macrophages, initiate fibrosis by the release of
soluble factors,2,3 among which TGF-b is one of the best
characterized.1,4 Other profibrotic mediators include the
platelet-derived growth factor (PDGF), IL-4, IL-6, IL-13.1,2,5 All
of these cytokines stimulate the production and deposition of
collagen by fibroblasts and promote their activation and
differentiation into myofibroblasts.1,2,5 Mu¨ller glial cells are
known to activate fibroblasts and to promote fibrotic changes
within the eye, such as proliferative vitreoretinopathy (PVR)3,6
and the formation of epiretinal membranes (ERMs).7,8 Epiretinal
membranes are characterized by the growth of fibrocellular
tissue along the inner limiting membrane (ILM), which can lead
to metamorphopsia and visual loss. The most frequently
encountered, so-called idiopathic ERMs, are not linked to any
other ocular disease process and their pathogenesis remains
unidentified. Macular holes (MHs), on the other hand, are full-
thickness foveal defects, extending from the ILM to the RPE.
The release of vitreomacular traction (VMT) as the underlying
pathomechanism of idiopathic macular holes9,10 leads to
degenerative and atrophic changes, including the formation of
prominent, cystoid spaces at the edge of the MH, which may
result in its enlargement without detectable scar formation in
more than 50% of the cases.11,12 In the remaining instances, a
horizontal traction, which is represented by a hyperreflective
band in optical coherence tomography on the inner retinal
surface with or without wrinkling of the retina, is visible. This
phenomenon is probably the consequence of either ILM-
contraction or of the formation of a thin ERM. In these cases,
enlargement of the MH, resulting from both a contraction of the
ERM and atrophic changes, is to be expected.13
In various ocular diseases, such as proliferative diabetic
retinopathy, retinal vein occlusion, uveitis, retinal detachment,
high myopia, and lymphoma, the vitreal levels of many
cytokines are elevated.14–18 In several of the published reports,
patients with vitreomacular pathologies, such as MHs or ERMs,
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were used as controls,14,16–18 even though the vitreal cytokine
profiles in these vitreoretinal interface diseases have not as yet
been well characterized or compared.
The aim of the present study was therefore to compare the
vitreal cytokine profiles in patients with either idiopathic ERMs
or idiopathic full-thickness MHs, with a view to assessing the
degree to which fibrotic and inflammatory processes contrib-
ute to the progression of these diseases.
PATIENTS AND METHODS
Patients
This prospective clinical study included patients with symp-
tomatic idiopathic ERMs or MHs requiring vitrectomy. Surgery
was performed at the Berner Augenklinik am Lindenhofspital
in Bern with the informed, written consent of the individuals
concerned. Clinical data pertaining to the systemic and
ophthalmologic diagnosis, the treatment strategy, and the
duration of the ocular symptoms were documented. Patients
with systemic comorbidities, that is, with diabetes mellitus, a
history of intraocular surgery (other than uneventful phaco-
emulsification for senile cataract, performed minimally 6
months before vitrectomy), ocular trauma, vitreal hemorrhag-
ing, uveitis, glaucoma, or any concomitant retinal pathology,
were excluded. Vitreal samples from patients with coexisting
ERMs and MHs in the same eye were also collected and the
data is presented in the Supplementary Material. The study was
approved by the local Institutional Ethics Board of the
University of Bern, Switzerland (registration number: 152/08)
and fully complied with the tenets of the Declaration of
Helsinki.
Collection of Vitreal Samples
Aliquots of native vitreous (approximately 0.5 mL) were
collected between January 2012 and April 2014 at the onset
of 23-G pars plana vitrectomy, after the insertion of the ports
and before opening the infusion line. The samples were stored
at208C for up to 2 months and thereafter at808C until all of
the specimens had been collected for the in-parallel analysis.
Cytokine Analysis
The vitreal samples were analyzed using a multiplex system
(Bio-Plex 100 array reader with Bio-Plex Manager software
[version 6.1]; Bio-Rad, Hercules, CA, USA). Using this system,
multiple analytes can be detected and quantified in parallel in a
single small sample volume. In the present study, the
concentrations of 43 cytokines in each vitreous sample (Table)
were quantified. All analytic procedures were performed
according to the manufacturer’s guidelines. In short, magnetic
microspheres that were tagged with a fluorescent label were
coupled to specific capture antibodies and mixed with samples
containing unknown quantities of the cytokines. Biotinylated
detection antibodies and Streptavidin R-Phycoerythrin were
then introduced. The mixture was analyzed by flow cytometry.
The instrument’s two lasers identify the microsphere type and
quantify the amount of bound antigen. A concentration standard
was run in parallel on each test plate. The measurements were
performed in a blinded manner by a laboratory technician who
was experienced in the execution of the technique.
Because the number of the selected cytokines was large, the
data were presented in the form of a color-coded heat map in
which the lowest values were depicted in light green and the
highest in red.
Statistical Analysis
Numerical data are presented as mean values together with the
SD. The concentrations of several of the cytokines lay below
the curve fit of the standards. To avoid the bias that would have
been introduced by excluding these values, they were set at
half of the lowest quantified level for the cytokine in question.
Outliers (values that lay 1.5 box lengths beyond the box edges)
were, on the basis of box-plot inspection, preexcluded from
the statistical analysis.
The Shapiro-Wilk test was instrumented to establish
whether the data were normally distributed. Because the
criteria for a normal distribution were not satisfied, the
nonparametric Mann-Whitney U test was implemented for the
intergroup comparisons. To avoid the introduction of type I
errors, Bonferroni’s correction was applied to the preset level
of significance (P < 0.05).19 For this purpose, the P value was
divided by the number of the cytokines whose concentrations
were determined (n ¼ 43), which resulted in a shift of the
level of significance from P < 0.05 to P < 0.0012. The
statistical analysis was performed using SPSS (version 23.0;
IBM SPSS Statistics, Armonk, NY, USA).
RESULTS
Patients
The two groups of patients (ERM: n ¼ 31; MH: n ¼ 30) were
composed of individuals of comparable age at the time of
inclusion (73 6 8.5 vs. 71 6 8.2 years in the ERM and MH
groups, respectively [P ¼ 0.3]). According to the medical
histories of the patients, the interval that elapsed between the
first reported symptoms and surgery was longer than 6 months
in 94% of the individuals in the ERM group and 27% of those in
the MH group. Symptoms of less than 3 months were reported
by 73% of patients with MH. Cataract surgery had been
performed minimally 6 months before inclusion in 26% of the
individuals in the ERM group and in 13% of those in the MH
group.
Cytokine Analyses
The absolute concentrations of the cytokines in the vitreal
fluid spanned a broad range that was specific for each type
(Table).
The levels of 31 of the cytokines (72%) were higher in the
ERM than in the MH group (Table; Figs. 1, 2). (These cytokines
were the following: CCL21, CXCL13, CCL27, CXCL5, CCL24,
CCL26, CCL11, CXCL6, CXCL1, CXCL2, CCL1, IFN-c, IL-10, IL-
16, IL-1b, IL-2, IL-4, IL-6, IL-8, CXCL11, CCL8, CCL7, CCL13,
CCL22, CXCL9, CCL3, CCL19, CCL23, CXCL12, CCL25, and
TNF-a.) The differences between the two groups remained
significant for each of the 31 cytokines also after the exclusion
of outliers. For the other 12 cytokines (granulocyte-macro-
phage colony-stimulating factor [GM-CSF], CXCL10, MCP-1,
MIF, CCL15, CCL20, CCL17, CX3CL1, CXCL16, and TGF-b-1, -2,
and -3), the levels in the two groups were similar.
Interestingly, the distribution of the 43 cytokines in Figure 1
suggests a specific cytokine profile in the vitreous, with higher
levels in the ERM group.
The largest intergroup differences, which were on the order
of 10-fold, were registered for CCL27, CCL26, CXCL6, INF-c, IL-
10, and CXCL11. These data are separately displayed in Figure
2. For each of these six cytokines, the concentrations lay in the
lower range (below the cutoff level) in 20% of the ERM- and in
63% to 100% of the MH-group samples (Fig. 3).
In 31.9% of the measured samples in both groups, the
concentrations of the cytokines lay below the limit of detection
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(Fig. 3). In no instance did the concentrations exceed the
detection limit. The percentage of samples in which the
cytokine levels fell below the limit of detection was
significantly higher in the MH (51.7%) than in the ERM (12%)
group (Fisher’s exact test: P < 0.001). This finding reflects the
differences in signaling activity between the two groups.
Presentation of the concentrations of the 43 cytokines in
the form of a color-coded heat map affords a good overview of
the profile differences between the two groups (Fig. 4). That
the concentrations of most of the cytokines were higher in the
ERM than in the MH group is abundantly apparent from the
overwhelming predominance of the color red (high levels)
over green (low levels) (Fig. 4).
DISCUSSION
Samples of vitreal fluid from eyes with idiopathic ERMs and/or
idiopathic MHs have served in many studies as controls for
cytokine analyses in various ocular pathologies.14–18 Somewhat
surprisingly, but probably owing to the high costs of these
analyses and an anticipated low scientific impact, comparative
data pertaining to the vitreal cytokine levels in patients with
ERMs and MHs are very sparse. In one such analysis, no
differences in the vitreal levels of high-abundance proteins
were detected between eyes with either idiopathic ERMs or
idiopathic MHs.20 On the basis of the vitreal cytokine levels in
the two groups, we show for the first time that the pathologic
progression of idiopathic ERMs and of idiopathic MHs cannot
be assumed to involve similar processes as pertaining to the
cell-stimulation levels of these molecules.
The finding that the vitreal levels of 72% of the selected
cytokines were higher in the ERM than in the MH group
implies that the specificity of the results is not so readily
interpretable even when it is based on highly conservative
statistical probability assumptions. The circumstance that a
close interrelationship and hierarchy exists between several
types of cytokines renders an interpretation of the data even
more complex.
In the present study, exclusion of the few outliers in the
upper concentration range had no impact on the statistical
outcomes. However, a substantial portion of the cytokine
concentrations lay close to or below the lower cutoff level (Fig.
3). Other investigators have solved this problem by fixing the
levels of the cytokines in question at half of the lower cutoff
value. This policy was adopted also in the present study.
Although cytokines at such low levels are not likely to be of
biological relevance, an exclusion of the data would reduce the
number of valuable measurements by 12% (ERMs) to more
than 50% (MHs), which would not only lead to a relevant
change in the mean and the median cytokine values, but also
result in an imbalance for data interpretation if the portion of
samples below cutoff differs as in our samples. In the absence
of data pertaining to the ‘‘normal’’ (physiological) values for
specific cytokines in the vitreal humor, it is not possible to
ascertain whether the higher concentration in one group
represents an upregulation, or the lower value in the counter
one a downregulation. Because we do not know the levels of
given cytokines that are necessary for intercellular communi-
cation and for the driving of relevant changes in this milieu, we
are unable to assess the biorelevance of the measured
differences between the two pathologic groups. In these
analyses, we are generally dealing with cytokine levels that
FIGURE 1. Comparison of vitreal cytokine levels in the ERM and MH group on a logarithmic scale. Significant differences of P < 0.0012 after
Bonferroni correction (marked with an asterisk).
FIGURE 2. Selection of cytokines with the largest intergroup difference
between the ERM and MH groups.
Vitreal Cytokine Profiles for ERM or MH IOVS j November 2016 j Vol. 57 j No. 14 j 6323
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935850/ on 03/23/2017
approach the lower limits of the test system’s sensitivity.
Hence, it may be necessary to develop new modes of data
analysis before we can move forward in this area. It would be
conceivable, for example, to generate a microarray-based
system to estimate the whole intercellular communication
environment, a cytokinome comparable with the proteinome
generated by proteomic microarrays. We chose also an
alternative approach to present and compare the assembled
data for the selected cytokines en bloc, in the form of a color-
coded heat map (Fig. 4), which facilitates interpretation of
intergroup outcomes using visualization technique instead of a
bulk of quantitative data.
FIGURE 3. Percentage of samples with nondetectable cytokine levels (out of range) in the ERM and MH groups.
FIGURE 4. Visualization of the intergroup differences using a heat map chart for all 43 cytokines (light green indicates low levels, whereas dark red
indicates elevated levels).
Vitreal Cytokine Profiles for ERM or MH IOVS j November 2016 j Vol. 57 j No. 14 j 6324
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935850/ on 03/23/2017
In addition, we have confirmation of our data in that at least
some of our measured vitreal cytokine levels show levels that
are comparable to already published data using the Bio-Plex
technique (i.e., for IL-1b, IL-4, IL-8, and TNF-a).15,21,22
Vitreomacular interface disorders, such as vitreomacular
traction, can result in the formation of MHs. The persistence of
such a disturbance can lead to the growth of ERMs, which may
or may not be associated with the formation of MHs.23 It is not
currently known whether ERMs and MHs result primarily from
a vitreal or from a retinal pathology. Our data suggest that ERMs
and MHs progress along different pathophysiologic courses.
Acute mechanical traction is believed to be the leading cause of
MHs, which is released on their clinical manifestation. By this
time, and thus at the time of surgery, the cytokine response to
the mechanical traction has abated. In the case of ERMs, the
mechanical traction is chronic, and the cytokine response
thereto is sustained until, and is still evident at, the time of
surgery, and may contribute to the progression of the disease.
Because the vitreal samples were collected during the chronic
phase of the diseases, we can do no more than speculate on
the cell-signaling roles of the cytokines in the pathologic
processes. Because the cytokine levels for MHs that coexisted
with ERMs in the same eye were comparable to those that
were characteristic of ERMs (data presented in the Supple-
mentary Material), it is conceivable that the vitreomacular-
traction–induced formation of MHs and ERMs is associated
with a trauma-induced activation of cytokine production,
which rapidly abates in the former pathology (MHs) but
persists in response to a persistent traction in the latter (ERMs).
From a histopathologic point of view, the fibrotic process
that is associated with the growth of ERMs involves diverse cell
types, including hyalocytes, fibroblasts, and glia cells,24 which
are activated by different fibroblast-signaling pathways and
which participate in the secretion of extracellular-matrix
components.25 Activated Mu¨ller glia cells contribute to the
formation of ERMs. Transforming growth factor–b induces the
differentiation of these cells into a fibroblast-like phenotype
and promotes their migration.7,8 Characteristic cytokine
profiles for the differentiation of fibroblasts and retinal glia
are unknown, but we assume activated fibroblasts as a source,
but not so evidently Mu¨ller glia cells, in the chronic phase of
ERM formation. The cytokine profiles in our study are
commensurate with an activation of fibrotic and inflammatory
processes, which are associated with elevated levels of IL-6, IL-
4, IL-1b, TNF-a, IL-10, IL-2, and INF-c (among others).2,26–28 In
our study, five of the six chemokines and cytokines with the
largest intergroup differences (CCL27, CCL26, CXCL6, INF-c,
and CXCL11) are proinflammatory and play a major role in
immunomodulation and inflammation, indicating a central role
of inflammatory mechanisms in epiretinal membrane forma-
tion. Additionally, IL-10 was initially understood as a TH2
cytokine with regulatory properties in inflammatory processes,
but meanwhile it was revealed that lymphocytes, macrophag-
es, dendritic, natural killer, and mast cells also express IL-10.29
Its contribution to fibrosis has remained controversial.29 The
upregulation of vitreal IL-10 levels in our ERM group might
indicate its immunomodulatory role in response to the
proinflammatory cytokines and chemokines so as to reconsti-
tute a physiological balance. In the vitreal humor of eyes with
MHs, the concentrations of proinflammatory cytokines did not
attain relevant levels.
Interestingly, TGF-b-2 was the most abundant TGF subtype
in our study, whereas in previous reports, TGF-b-1 was
identified as the more relevant cytokine in the formation of
ERMs.24,30 Transforming growth factor–b-1 and the nerve
growth factor were shown to play a crucial role in fibroblast
activities and were detected in the vitreal humor of each of the
eight patients with idiopathic ERMs.30 Kohno et al.25 demon-
strated that TGF-b-2 stimulates the differentiation of hyalocytes
into myofibroblasts. Interestingly, Zhao et al.31 reported
hyalocytes and retinal Mu¨ller cells to be the predominant cell
types in idiopathic ERMs. Transforming growth factor–b-2 thus
appears to be an important growth factor in the evolution of
ERMs and in their contraction.25,32 In our study, the vitreal
levels of TGF-b-2 in the ERM group were higher than those of
TGF-b-1 and -3. However, such was the case also in the MH
group, which is a seemingly unaccountable finding. Neverthe-
less, the question remains unanswered whether cytokine levels
in general, namely TGF-b levels are similar throughout the
whole vitreous in these macular pathologies.
In conclusion, an activated cytokine profile exists in the
vitreal humor of patients with ERM but not in that of
individuals with MHs during the chronic phase of the diseases.
The lack of such a response in the MH group reflects the
absence of a fibrotic switch after the induction of the initial
mechanical trauma, the nature of which may have been the
same in both pathologies.
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